Literature DB >> 10548299

Risk factors for death and changing patterns in leptospirosis acute renal failure.

E Daher1, D M Zanetta, M B Cavalcante, R C Abdulkader.   

Abstract

The risk factors for death and changes in clinical patterns in leptospirosis (Weil's disease) have not been well studied. We retrospectively studied 110 patients with Weil's disease hospitalized in Brazil between 1985 and 1996. Univariate statistical analysis showed that nonsurvivors were older than survivors, and had higher frequency of oliguria, cardiac arrhythmia, dyspnea, and pulmonary rales. Logistic regression showed that the only independent factor associated with death was oliguria (odds ratio [OR] = 8.98). The presence of arthralgia (OR = 4.71), dehydration (OR = 6.26), dyspnea (OR = 17.7), and pulmonary rales (OR = 9.91) increased after 1994. These data suggest that in Weil's disease the clinical patterns have changed and the presence of oliguria is a risk factor for death.

Entities:  

Mesh:

Year:  1999        PMID: 10548299     DOI: 10.4269/ajtmh.1999.61.630

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  26 in total

Review 1.  Leptospirosis.

Authors:  P N Levett
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

2.  Predictors of lethality in severe leptospirosis in urban Brazil.

Authors:  Anne S Spichler; Pedro J Vilaça; Daniel A Athanazio; Jose O M Albuquerque; Marcia Buzzar; Bronislawa Castro; Antonio Seguro; Joseph M Vinetz
Journal:  Am J Trop Med Hyg       Date:  2008-12       Impact factor: 2.345

Review 3.  The kidney in leptospirosis.

Authors:  Regina C R M Abdulkader; Marcos Vinicius Silva
Journal:  Pediatr Nephrol       Date:  2008-04-30       Impact factor: 3.714

4.  Diagnosis of human leptospirosis by monoclonal antibody-based antigen detection in urine.

Authors:  Patcharin Saengjaruk; Wanpen Chaicumpa; George Watt; Gaysorn Bunyaraksyotin; Vanaporn Wuthiekanun; Pramuan Tapchaisri; Chuanpit Sittinont; Thanachai Panaphut; Kanchana Tomanakan; Yuwaporn Sakolvaree; Manas Chongsa-Nguan; Yuvadee Mahakunkijcharoen; Thareerat Kalambaheti; Pimjai Naigowit; Michael Angelo L Wambangco; Hisao Kurazono; Hideo Hayashi
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

5.  High serum nitric oxide levels in patients with severe leptospirosis.

Authors:  Elves A P Maciel; Daniel A Athanazio; Eliana A G Reis; Fernando Q Cunha; Adriano Queiroz; Deusdelia Almeida; Alan J A McBride; Albert I Ko; Mitermayer G Reis
Journal:  Acta Trop       Date:  2007-01-02       Impact factor: 3.112

6.  Differences in clinical manifestations of imported versus autochthonous leptospirosis in Austria and Germany.

Authors:  Bodo Hoffmeister; Gabriele Peyerl-Hoffmann; Sven Pischke; Ines Zollner-Schwetz; Robert Krause; Matthias C Müller; Angelika Graf; Stefan Kluge; Gerd D Burchard; Winfried V Kern; Norbert Suttorp; Jakob P Cramer
Journal:  Am J Trop Med Hyg       Date:  2010-08       Impact factor: 2.345

Review 7.  Leptospirosis in humans.

Authors:  David A Haake; Paul N Levett
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

Review 8.  Clinical and imaging manifestations of hemorrhagic pulmonary leptospirosis: a state-of-the-art review.

Authors:  Edson Marchiori; Sílvia Lourenço; Sérgio Setúbal; Gláucia Zanetti; Taisa Davaus Gasparetto; Bruno Hochhegger
Journal:  Lung       Date:  2010-12-09       Impact factor: 2.584

9.  Severity markers in severe leptospirosis: a cohort study.

Authors:  M Mikulski; P Boisier; F Lacassin; M-E Soupé-Gilbert; C Mauron; L Bruyere-Ostells; D Bonte; Y Barguil; A-C Gourinat; M Matsui; F Vernel-Pauillac; C Goarant
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-11-21       Impact factor: 3.267

10.  Cyclophosphamide in pulmonary alveolar hemorrhage due to leptospirosis.

Authors:  Samir V Trivedi; Ashwin H Vasava; Tinkal C Patel; Lovleen C Bhatia
Journal:  Indian J Crit Care Med       Date:  2009 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.